Hypnosis: a Path to Appeasement
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: anxiety questionnaire.
- Who it may be relevant to
- Registry conditions: Hematologic Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...). The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need. Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
Interventions
- Other anxiety questionnaire
Patient undergoing hypnosis session will have their anxiety measured just before the third session of hypnosis and after during a telephonic consultation. The result will be compared to the anxiety level before the first hypnosis session
Primary outcome measures
- Evolution of anxiety [Time frame: Week 6 after 2 hypnosis sessions]
Secondary outcome measures (7)
- Evolution of anxiety before hypnotherapy and after 3 months of follow-up in hypnotherapy [Time frame: Month 3 after 3 hypnosis sessions]
- Evolution of anxiety between D0 and M3 according to the type of lymphoma [Time frame: Month 3 after 3 hypnosis sessions]
- Evolution of anxiety between D0 and W6 according to the type of lymphoma [Time frame: Week 6 after 2 hypnosis sessions]
- Evolution of anxiety between D0 and W6 according to the gender of the patient [Time frame: Week 6 after 2 hypnosis sessions]
- Evolution of anxiety between D0 and M3 according to the gender of the patient [Time frame: Month 3 after 3 hypnosis sessions]
- Evolution of anxiety between D0 and W6 according to age category [Time frame: Week 6 after 2 hypnosis sessions]
- Evolution of anxiety between D0 and M3 according to age category [Time frame: Month 3 after 3 hypnosis sessions]
Eligibility criteria
Inclusion criteria
- Patients over 18 years old, fluent in French.
- Patients starting hypnotherapy for anxiety disorders.
- Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21
- Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease.
- Diagnosis announcement less than 2 months old
Exclusion criteria
- Persons deprived of their liberty by a judicial or administrative decision
- Adults subject to a legal protection measure
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Basic science
Study locations
France · 1 center
- Service MB1 - Hôpital Lyon Sud - HCL — Lyon
Identifiers
NCT: NCT05942885 · 69HCL23_0336